based on this hypothesis a therapeutic trial with flufenamic acid ( a prostaglandin inhibitor of the fenamates group ) was conducted during 1 year in 5 patients suffering from recurrent ophthalmoplegic migraine .
C0016282
flufenamic acid
C1955898
fenamates